Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12358983 | Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof | Konstantin Petropoulos, Peter Kelemen, Rainer Boxhammer, Markus Rückert | 2025-07-15 |
| 12194095 | Combinations and uses thereof | Mark Winderlich, Rainer Boxhammer | 2025-01-14 |
| 11591406 | Treatment for multiple myeloma (MM) | Stephane Leclair, Stefan Härtle | 2023-02-28 |
| 11224654 | Combinations and uses thereof | Mark Winderlich, Rainer Boxhammer | 2022-01-18 |
| 10617691 | Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof | Rainer Boxhammer, Mark Winderlich | 2020-04-14 |
| 10533057 | Treatment for multiple myeloma (MM) | Stephane Leclair, Stefan Härtle | 2020-01-14 |
| 10308722 | Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide | Lisa Rojkjaer, Rainer Boxhammer, Mark Winderlich, Christofer Samuelsson | 2019-06-04 |
| 9765152 | Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib | Lisa Rojkjaer, Rainer Boxhammer, Mark Winderlich, Christofer Samuelsson | 2017-09-19 |
| 9579378 | Combinations and uses thereof | Lisa Rojkjaer | 2017-02-28 |
| 9289490 | Combinations and uses thereof | Lisa Rojkjaer, Rainer Boxhammer, Mark Winderlich, Christofer Samuelsson | 2016-03-22 |
| 8877899 | Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL | Lisa Rojkjaer, Rainer Boxhammer, Mark Winderlich, Christofer Samuelsson | 2014-11-04 |